BNP PARIBAS FINANCIAL MARKETS - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 56 filers reported holding RECRO PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$121
-57.2%
2570.0%0.00%
Q2 2023$283
-7.5%
2570.0%0.00%
Q1 2023$306
-35.2%
257
-18.9%
0.00%
Q4 2022$472
-99.9%
3170.0%0.00%
Q3 2022$517,000
+105.2%
3170.0%0.00%
Q2 2022$252,000
-55.9%
3170.0%0.00%
Q1 2022$571,000
+5.4%
3170.0%0.00%
Q4 2021$542,000
-17.0%
3170.0%0.00%
Q3 2021$653,000
-95.4%
317
-94.8%
0.00%
Q2 2021$14,079,000
+14.8%
6,095
+38.6%
0.00%
Q1 2021$12,265,000
+10.4%
4,396
+12.7%
0.00%
Q4 2020$11,112,000
+7.5%
3,899
-20.8%
0.00%
Q3 2020$10,334,000
+231.5%
4,921
+618.4%
0.00%
Q2 2020$3,117,000
-93.7%
685
-88.8%
0.00%
Q1 2020$49,853,000
-8.5%
6,102
+105.2%
0.00%
Q4 2019$54,513,000
+69.0%
2,974
+2.2%
0.00%
Q3 2019$32,254,000
+57.0%
2,911
+44.1%
0.00%
Q2 2019$20,543,000
-6.6%
2,020
-46.2%
0.00%
Q1 2019$21,987,000
+60975.0%
3,752
+74940.0%
0.00%
Q4 2018$36,000
-99.1%
5
-99.1%
0.00%
Q3 2018$4,181,000
+41.6%
5880.0%0.00%
Q2 2018$2,952,000
-90.8%
588
-79.8%
0.00%
Q1 2018$32,017,000
-6.2%
2,908
-21.2%
0.00%
Q4 2017$34,132,000
+186.0%
3,690
+177.7%
0.00%
Q3 2017$11,934,000
+19.0%
1,329
-6.9%
0.00%
Q2 2017$10,032,000
-91.7%
1,427
-85.7%
0.00%
Q3 2015$120,300,000
-6.9%
10,0000.0%0.00%
Q2 2015$129,200,00010,0000.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Engine Capital Management, LP 1,104,546$11,233,0005.38%
Broadfin Capital, LLC 1,561,617$15,882,0003.46%
Corsair Capital Management 742,900$7,555,0002.21%
NORTH RUN CAPITAL, LP 315,338$3,207,0002.18%
Fondren Management LP 95,000$966,0000.92%
Leap Investments LP 25,611$260,0000.35%
ESSEX INVESTMENT MANAGEMENT CO LLC 213,002$2,166,0000.30%
Campbell & CO Investment Adviser LLC 38,989$397,0000.18%
Opus Point Partners Management, LLC 11,353$115,0000.17%
Penn Capital Management Company, LLC 149,946$1,525,0000.15%
View complete list of RECRO PHARMA INC shareholders